MedicarePartD.guide

A non-government resource built from CMS public data

SGLT2 inhibitors on every 2026 Oklahoma Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in Oklahoma cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

11 plans, cheapest premium first. Scroll sideways for all of them →

SGLT2 inhibitors by 2026 Oklahoma Part D plan
DrugBlue Cross MedicareRx Basic$0.00/moS5715-015Humana Basic Rx Plan$0.00/moS5884-144Wellcare Value Script$5.60/moS4802-156Wellcare Classic$5.70/moS4802-014Humana Value Rx Plan$33.70/moS5884-202HealthSpring Extra Rx$65.40/moS5617-373AARP Medicare Rx Saver from UHC$82.40/moS5921-368Humana Premier Rx Plan$108.60/moS5884-169AARP Medicare Rx Preferred from UHC$121.00/moS5921-404HealthSpring Assurance Rx$126.50/moS5617-113Blue Cross MedicareRx Value$167.30/moS5715-010
JardianceempagliflozinTier 316%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 317%QL 30/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dTier 316%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30d
FarxigadapagliflozinNot coveredTier 325%QL 30/30dNot coveredNot coveredTier 320%QL 30/30dTier 317%QL 30/30dNot coveredTier 3$45.00QL 30/30dNot coveredTier 320%QL 30/30dNot covered
dapagliflozingeneric FarxigaTier 316%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 317%QL 30/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dTier 316%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30d
InvokanacanagliflozinNot coveredNot coveredTier 440%QL 60/30dTier 426%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SteglatroertugliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
InpefasotagliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.